SARS-CoV-2: Virology, epidemiology, immunology and vaccine development

Biologicals. 2020 Jul:66:35-40. doi: 10.1016/j.biologicals.2020.06.005. Epub 2020 Jun 23.

Abstract

This first International Alliance for Biological Standardization Covid-19 webinar brought together a broad range of international stakeholders, including academia, regulators, funders and industry, with a considerable delegation from low- and middle-income countries, to discuss the virology, epidemiology and immunology of, and the vaccine development for SARS-CoV-2.

Keywords: Epidemiology; Immunology; SARS-CoV-2; Vaccine development; Virology.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Basic Reproduction Number
  • Betacoronavirus*
  • COVID-19
  • COVID-19 Vaccines
  • Congresses as Topic
  • Coronavirus Infections / epidemiology
  • Coronavirus Infections / immunology*
  • Coronavirus Infections / prevention & control*
  • Coronavirus Infections / virology
  • Drug Design
  • Female
  • Global Health
  • Humans
  • International Cooperation
  • Internet
  • Male
  • Middle Aged
  • Pandemics / prevention & control*
  • Pneumonia, Viral / epidemiology
  • Pneumonia, Viral / immunology*
  • Pneumonia, Viral / prevention & control*
  • Pneumonia, Viral / virology
  • Reference Standards
  • SARS-CoV-2
  • Seasons
  • Telecommunications
  • Viral Vaccines*
  • Virology / trends
  • Young Adult

Substances

  • COVID-19 Vaccines
  • Viral Vaccines